Malaria
Malaria causes nearly 800,000 deaths, mostly in sub-Saharan African infants and children, and there are an estimated 300 million to 500 million cases of the disease every year. Malaria can be controlled through the use of medicines, insecticides, and insecticide-treated screens and bednets, and can be treated with antimalarial drugs. Currently, there is no licensed vaccine against malaria; however, several vaccines are under development.
More about malaria | View resources on malaria
Key resources
Community Perceptions of Malaria and Vaccines in the South Coast and Busia Regions of Kenya (2011)
A study that explores sociocultural and health communications issues related to the future introduction of a malaria vaccine.
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children (2011)
An article that reports a 50 percent reduction rate of clinical episodes of malaria in vaccine trial participants.
Featured PATH resources
10 Tips for Successful Malaria Vaccine Advocacy (2012)
A booklet that presents advocacy information to help ensure that policymakers
have the information they need to introduce a first malaria vaccine once it is available.
Staying the Course? Malaria Research and Development in a Time of Economic Uncertainty (2011)
A report that shines a spotlight on recent trends in investments in malaria research and development.
Page last updated: May 2012.

